 Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores
Antony Waste Handling Cell Ltd Q2 FY2026 consolidated net profit down QoQ to Rs. 13.65 crores Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore
Eiko Lifesciences Ltd Q2FY26 consolidated PAT increases to Rs. 1.07 crore LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores
LG Balakrishnan and Bros Ltd Q2 FY2026 consolidated net profit soars to Rs. 93.62 crores Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26
Mahindra Holidays and Resorts India Ltd posts higher consolidated PAT of Rs. 17.85 crores in Q2FY26 Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores
Balkrishna Industries Ltd consolidated Q2FY26 PAT falls to Rs. 273.19 crores 
              Svaks Biotech India Pvt Ltd (SBIPL), the Promoter of Lasa Supergenerics Ltd continues to dump its shares through open market selling. The promoter entity sold 1,873 equity shares on Feb 15, 2018 at a price of Rs. 142 which reduced its stake from 106936 equity shares (0.47%)	to 105063 shares (0.46%).
It again sold 6556 equity shares on Feb 16, 2018 at a price of Rs. 135 through open market selling which reduced its stake further from 105063 shares (0.46%) to 98507 shares (0.43%).
Svaks Biotech India Pvt Ltd was holding 3,37,774 equity shares or 1.48% in Lasa as per the shareholding pattern on December 31, 2017.
Shares of Lasa Supergenerics Ltd was last trading in BSE at Rs.122.8 as compared to the previous close of Rs. 129.25. The total number of shares traded during the day was 82077 in over 469 trades.
The stock hit an intraday high of Rs. 128 and intraday low of 122.8. The net turnover during the day was Rs. 10117546.